2024 Predictions

Obesity Impact

Scott Galloway explores the profound economic implications of obesity and the introduction of GLP-1 drugs. He highlights how these drugs, which suppress cravings, could potentially reduce obesity-related costs that currently amount to $1.7 trillion in the U.S. economy 1. Scott argues that the impact of GLP-1 drugs might surpass even that of AI, as they address fundamental issues like addiction and unhealthy lifestyles 1.

Obesity has killed and continues to kill way more people than any pandemic. It's the number one preventable source of death.

--- Scott Galloway

He also notes that the market is already reacting, with companies like Novo Nordisk seeing significant valuation increases, while traditional food and beverage companies face potential declines 2.

   

Tech Shifts

In the tech sector, Scott predicts significant shifts, particularly in AI and tech stock valuations. He suggests that AI valuations have peaked and foresees established companies like Alphabet and Microsoft dominating the AI landscape, rather than new entrants 3. Scott also identifies Alphabet as his top tech stock pick for 2024, citing its diversified business model and strategic advantages, such as YouTube's growth in India 3.

The Empire strikes back. And that is specifically Alphabet and Microsoft come for traditional AI companies.

--- Scott Galloway

Additionally, he anticipates geopolitical shifts, with India emerging as a key player in the tech market, potentially replacing China in importance 4.